PTAB challenges

Proceedings overview

US Patent 7,822,639 has been the subject of three AIA trial proceedings, all of which were Inter Partes Reviews (IPR) or Covered Business Method (CBM) reviews that were denied institution on the merits. This outcome indicates that the Patent Trial and Appeal Board (PTAB) found the petitioners failed to demonstrate a reasonable likelihood of success in invalidating any of the challenged claims. Consequently, all claims of the patent have been sustained through these challenges, suggesting a hardened defensive posture for the patent owner.

IPR2022-01453 — Unified Patents LLC v. Almondnet Inc.

• Type: Inter Partes Review
• Filed: Information not found in public search results.
• Status: Not Instituted - Merits. The PTAB denied institution, concluding that the petition did not demonstrate a reasonable likelihood that at least one challenged claim of U.S. Patent 7,822,639 was unpatentable.
• Judge panel: Information not found in public search results.
• Petition grounds: Specific claims challenged, prior art cited, and statutory bases (§ 102 / § 103) are not detailed in publicly available search snippets.
• Institution decision: Denied on the merits. The exact date and full reasoning of the denial are not provided in the public search results, but the denial implies the petitioner did not meet the threshold for institution.
• Final Written Decision: Not issued, as institution was denied.
• Settlement / termination: Not applicable.
• Appeal: No appeal possible, as institution was denied.
• Defensive value: This proceeding demonstrates that the claims challenged by Unified Patents in IPR2022-01453 were deemed sufficiently robust by the PTAB to withstand an initial challenge. A defendant facing assertion of this patent should note that these specific grounds, whatever they were, were found unconvincing by the PTAB.

IPR2022-00928 — Unified Patents LLC v. Almondnet Inc.

• Type: Inter Partes Review
• Filed: Information not found in public search results.
• Status: Not Instituted - Merits. The PTAB denied institution, indicating that the petition failed to establish a reasonable likelihood of proving unpatentability for any of the challenged claims of U.S. Patent 7,822,639.
• Judge panel: Information not found in public search results.
• Petition grounds: Specific claims challenged, prior art cited, and statutory bases (§ 102 / § 103) are not detailed in publicly available search snippets.
• Institution decision: Denied on the merits. The specific date and comprehensive reasoning for the denial are not available in the provided search results.
• Final Written Decision: Not issued, as institution was denied.
• Settlement / termination: Not applicable.
• Appeal: No appeal possible, as institution was denied.
• Defensive value: Similar to IPR2022-01453, this denial suggests that the PTAB found the prior art and arguments presented against the challenged claims in IPR2022-00928 to be insufficient for proceeding to trial. This strengthens the patent owner's position regarding the patentability of the claims.

CBM2017-00046 — Unified Patents LLC v. Almondnet Inc.

• Type: Covered Business Method (CBM) Review
• Filed: Information not found in public search results.
• Status: Not Instituted - Merits. The PTAB denied institution of this CBM review, determining that the petitioner did not show a reasonable likelihood that at least one challenged claim of U.S. Patent 7,822,639 was unpatentable.
• Judge panel: Information not found in public search results.
• Petition grounds: Specific claims challenged, prior art cited, and statutory bases (§ 101 / § 102 / § 103 / § 112) are not detailed in publicly available search snippets.
• Institution decision: Denied on the merits. The exact date and full reasoning of the denial are not provided in the public search results.
• Final Written Decision: Not issued, as institution was denied.
• Settlement / termination: Not applicable.
• Appeal: No appeal possible, as institution was denied.
• Defensive value: The denial of a CBM review, particularly on the merits, indicates that the patent was found to not be a "covered business method patent" that was unpatentable under the CBM rules, or that the arguments for unpatentability were not compelling. This provides strong defensive value for the patent owner, as CBMs have a broader scope for challenging patentability, including § 101 grounds.

Strategic summary

All three identified PTAB proceedings concerning US Patent 7,822,639 were challenges brought by Unified Patents LLC against Almondnet Inc.. In all instances (IPR2022-01453, IPR2022-00928, and CBM2017-00046), the PTAB denied institution of the trial on the merits. This means that no claims of US 7,822,639 have been canceled or found unpatentable through these PTAB proceedings. All claims of the patent remain SUSTAINED and UNTESTED by a full PTAB trial, as the petitions did not even clear the threshold for institution.

The estoppel landscape for these specific proceedings is relatively favorable to the patent owner. Since institution was denied in all cases, the petitioner (Unified Patents LLC) and its privies are estopped under 35 U.S.C. § 315(e)(1) from asserting in future district court or ITC actions any ground that they raised or could have reasonably raised in these petitions. This makes it harder for Unified Patents or its members to challenge the patent on the same prior art or arguments in subsequent litigation. However, other parties not in privity with Unified Patents would not be estopped.

A clear pattern signal here is that Unified Patents, a defensive aggregator known for challenging patents asserted against its members, specifically targeted this patent multiple times (two IPRs and one CBM). The consistent denial of institution on the merits suggests that the PTAB found the patent's claims to be resilient against the prior art and arguments presented by an experienced petitioner. This indicates a robust patent, at least against the challenges mounted by Unified Patents.

Recommended next steps

Given that all PTAB proceedings against US Patent 7,822,639 resulted in denials of institution on the merits, there are no claims that have been invalidated. The patent expired on April 10, 2023, so no new IPRs or CBMs can be filed.

For a defendant currently being asserted against, the key takeaway is that the patent owner, Almondnet Inc., has a history of successfully defending this patent against PTAB challenges by Unified Patents. This means that a defense strategy heavily reliant on IPR-type prior art challenges that were already presented or could have been presented in IPR2022-01453, IPR2022-00928, or CBM2017-00046 by Unified Patents would likely face an uphill battle due to the prior denials and potential estoppel implications.

However, the specific prior art and arguments used in the denied petitions are not publicly available from the search snippets. A defendant would need to:

1. Obtain the full institution decisions for IPR2022-01453, IPR2022-00928, and CBM2017-00046 from the USPTO PTAB E2E portal to understand the precise grounds challenged and the PTAB's reasoning for denial. This information is crucial for understanding the scope of estoppel and identifying any new, unlitigated prior art or arguments.
2. Evaluate whether any new prior art or different arguments could be mounted against the claims. While the patent has expired, its past validity is still relevant for past infringement damages.
3. Consider that the patent has expired. This shifts the focus of any current litigation to past damages rather than injunctive relief.